
CVS Health Ventures is a corporate venture capital fund that invests in high-potential, early-stage companies focused on making healthcare more accessible, affordable, and simpler. Its strategy aligns with CVS Health's vision, targeting areas like transforming care delivery, whole person care, consumer-centric health, and disruptive technology enablement.
94% of their portfolio is in Healthcare. Average disclosed round size is $91.6M (across 15 rounds with reported amounts).
Portfolio
17
Fund Size
$100M
Top Stage
Series C
Last 12 Mo
5
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
17 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series C | $35M | Feb 2026 | |
| Series B | $23.7M | Feb 2026 | |
| Series C | $35M | Dec 2025 | |
| Series D | $97M | Sep 2025 | |
| Series A | $45M | Jun 2025 | |
| Series C | $60M | Jan 2025 | |
| NNema Health | Series A | $14.5M | Jan 2025 |
| Series C | $95M | Jul 2024 | |
| Unknown | — | May 2024 | |
| Unknown | — | May 2024 | |
| Series D | $40M | Oct 2023 | |
| Series C | $166M | May 2023 | |
| MMaven Clinic | Series E | $90M | Nov 2022 |
| Series E | $90M | Nov 2022 | |
| Series C | $118M | Oct 2021 | |
| Growth | $375M | — | |
| Growth | $90M | — |
Top Co-Investors
.406 Ventures3 shared
AlleyCorp3 shared
General Catalyst3 shared
La Famiglia3 shared
Oak HC/FT3 shared
Frist Cressey Ventures3 shared
Sequoia Capital2 shared
Dragoneer Investment Group2 shared
Lux Capital2 shared
Icon Ventures2 shared
Ascension Ventures2 shared
Foresite Capital2 shared
a16z Bio + Health2 shared
Concord Health Partners2 shared
Deerfield1 shared
Optum Ventures1 shared
GreyMatter Capital1 shared
Blue Venture Fund1 shared
Gilde Healthcare1 shared
Redpoint Ventures1 shared
Last updated: 8 March 2026